The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

Researchers at the University of Toronto and University of Calgary have developed an innovative approach that uses artificial ...

Breast cancer patients who underwent postmastectomy breast reconstruction had lower sexual well-being scores compared with ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

Technology Networks caught up with Hartung after the event to discuss his insights on the future of drug testing, the role of AI in toxicology and the regulatory and ethical challenges in moving away ...

Patients expressed concern that overreliance on artificial intelligence (AI) could lead to clinicians losing their skills, ...

Dermatoscope imaging processed with AI has been in use in the UK for 4 years with accuracy shown to be at least equal to ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

AI assistance was seen to speed screening and recruitment for clinical trials, potentially helping patients access novel therapies faster.

Modern AI technology is data-hungry. In many areas, data is scarce. For example, in our work in early oncology clinical trials, we only have data on about 20 patients, so we tend to use theory-based ...

Insilico Medicine, an AI drug discovery company based in Hong Kong and Boston, has joined the unicorn club after raising $110 million in a funding round led by Hong Kong-headquartered asset ...